Alkylglyceronephosphate synthase (AGPS) alters lipid signaling pathways and supports chemotherapy resistance of glioma and hepatic carcinoma cell lines

Asian Pac J Cancer Prev. 2014;15(7):3219-26. doi: 10.7314/apjcp.2014.15.7.3219.

Abstract

Chemotherapy continues to be a mainstay of cancer treatment, although drug resistance is a major obstacle. Lipid metabolism plays a critical role in cancer pathology, with elevated ether lipid levels. Recently, alkylglyceronephosphate synthase (AGPS), an enzyme that catalyzes the critical step in ether lipid synthesis, was shown to be up-regulated in multiple types of cancer cells and primary tumors. Here, we demonstrated that silencing of AGPS in chemotherapy resistance glioma U87MG/DDP and hepatic carcinoma HepG2/ADM cell lines resulted in reduced cell proliferation, increased drug sensitivity, cell cycle arrest and cell apoptosis through reducing the intracellular concentration of lysophosphatidic acid (LPA), lysophosphatidic acid-ether (LPAe) and prostaglandin E2 (PGE2), resulting in reduction of LPA receptor and EP receptors mediated PI3K/AKT signaling pathways and the expression of several multi-drug resistance genes, like MDR1, MRP1 and ABCG2. β-catenin, caspase-3/8, Bcl-2 and survivin were also found to be involved. In summary, our studies indicate that AGPS plays a role in cancer chemotherapy resistance by mediating signaling lipid metabolism in cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B / biosynthesis
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters / biosynthesis
  • Alkyl and Aryl Transferases / genetics*
  • Apoptosis / genetics
  • Carcinoma, Hepatocellular / drug therapy*
  • Caspase 3 / biosynthesis
  • Caspase 8 / biosynthesis
  • Cell Cycle Checkpoints / genetics
  • Cell Line, Tumor
  • Cell Proliferation / genetics
  • Dinoprostone / metabolism
  • Drug Resistance, Neoplasm / genetics*
  • Glioma / drug therapy*
  • Hep G2 Cells
  • Humans
  • Inhibitor of Apoptosis Proteins / biosynthesis
  • Lipid Metabolism
  • Liver Neoplasms / drug therapy*
  • Lysophospholipids / metabolism
  • Multidrug Resistance-Associated Proteins / biosynthesis
  • Neoplasm Proteins / biosynthesis
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • RNA Interference
  • RNA, Small Interfering
  • Receptors, Lysophosphatidic Acid / metabolism
  • Signal Transduction
  • Survivin
  • beta Catenin / biosynthesis

Substances

  • ABCB1 protein, human
  • ABCG2 protein, human
  • ATP Binding Cassette Transporter, Subfamily B
  • ATP Binding Cassette Transporter, Subfamily G, Member 2
  • ATP-Binding Cassette Transporters
  • BIRC5 protein, human
  • Inhibitor of Apoptosis Proteins
  • Lysophospholipids
  • Multidrug Resistance-Associated Proteins
  • Neoplasm Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • RNA, Small Interfering
  • Receptors, Lysophosphatidic Acid
  • Survivin
  • beta Catenin
  • Alkyl and Aryl Transferases
  • alkylglycerone-phosphate synthase
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Caspase 3
  • Caspase 8
  • Dinoprostone
  • lysophosphatidic acid
  • multidrug resistance-associated protein 1